Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2008 1
2009 1
2010 3
2011 2
2012 5
2013 3
2014 3
2015 4
2016 2
2017 1
2018 1
2019 1
2020 1
2021 1
2022 4
2023 1
2024 4
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Heat-treated Limosilactobacillus fermentum LM1020 with menthol, salicylic acid, and panthenol promotes hair growth and regulates hair scalp microbiome balance in androgenetic alopecia: A double-blind, randomized and placebo-controlled clinical trial.
Bae WY, Jung WH, Shin SL, Kim TR, Sohn M, Suk J, Jung I, Lee YI, Lee JH. Bae WY, et al. J Cosmet Dermatol. 2024 Sep;23(9):2943-2955. doi: 10.1111/jocd.16357. Epub 2024 May 29. J Cosmet Dermatol. 2024. PMID: 38807549 Clinical Trial.
AIMS: In this study, heat-treated Limosilactobacillus fermentum LM1020 (HT-LM1020) was investigated in human follicle dermal papilla cell (HFDPC), scalp tissue, and clinical trials for patients with AGA. ...
AIMS: In this study, heat-treated Limosilactobacillus fermentum LM1020 (HT-LM1020) was investigated in human follicle dermal p …
Probiotic Lactobacillus fermentum TSF331, Lactobacillus reuteri TSR332, and Lactobacillus plantarum TSP05 improved liver function and uric acid management-A pilot study.
Lin JH, Lin CH, Kuo YW, Liao CA, Chen JF, Tsai SY, Li CM, Hsu YC, Huang YY, Hsia KC, Yeh YT, Ho HH. Lin JH, et al. PLoS One. 2024 Jul 24;19(7):e0307181. doi: 10.1371/journal.pone.0307181. eCollection 2024. PLoS One. 2024. PMID: 39046973 Free PMC article. Clinical Trial.
A placebo-controlled, double-blinded, randomized clinical trial was therefore conducted to explore the impacts of daily supplements with various combinations of the probiotics, Lactobacillus fermentum TSF331, Lactobacillus reuteri TSR332, and Lactobacillus plantarum TSP05 …
A placebo-controlled, double-blinded, randomized clinical trial was therefore conducted to explore the impacts of daily supplements with var …
Early life gut microbiota profiles linked to synbiotic formula effects: a randomized clinical trial in European infants.
Lagkouvardos I, Intze E, Schaubeck M, Rooney JP, Hecht C, Piloquet H, Clavel T. Lagkouvardos I, et al. Am J Clin Nutr. 2023 Feb;117(2):326-339. doi: 10.1016/j.ajcnut.2022.11.012. Epub 2022 Dec 21. Am J Clin Nutr. 2023. PMID: 36811568 Free article. Clinical Trial.
OBJECTIVES: This randomized, controlled intervention study included 540 infants to investigate the effects of a synbiotic intervention formula (IF) containing Limosilactobacillus fermentum CECT5716 and galacto-oligosaccharides on the fecal microbiome. ...
OBJECTIVES: This randomized, controlled intervention study included 540 infants to investigate the effects of a synbiotic intervention formu …
Efficacy and safety of a synbiotic infant formula for the prevention of respiratory and gastrointestinal infections: a randomized controlled trial.
Piloquet H, Vrignaud B, Gillaizeau F, Capronnier O, Berding K, Günther J, Hecht C, Regimbart C; GOLF III Study Group. Piloquet H, et al. Am J Clin Nutr. 2024 May;119(5):1259-1269. doi: 10.1016/j.ajcnut.2024.03.005. Epub 2024 Mar 10. Am J Clin Nutr. 2024. PMID: 38462218 Free article. Clinical Trial.
METHODS: In this double-blind, controlled trial, 460 healthy, 1-mo-old infants were randomly assigned to receive a synbiotic [galacto-oligosaccharides (GOS)/Limosilactobacillus fermentum CECT 5716] (IF, n = 230) or a control formula (CF, n = 230) until 12 mo of age. …
METHODS: In this double-blind, controlled trial, 460 healthy, 1-mo-old infants were randomly assigned to receive a synbiotic [galacto-oligos …
Effect of MED-02 Containing Two Probiotic Strains, Limosilactobacillus fermentum MG4231 and MG4244, on Body Fat Reduction in Overweight or Obese Subjects: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study.
Cho YG, Yang YJ, Yoon YS, Lee ES, Lee JH, Jeong Y, Kang CH. Cho YG, et al. Nutrients. 2022 Aug 30;14(17):3583. doi: 10.3390/nu14173583. Nutrients. 2022. PMID: 36079841 Free PMC article. Clinical Trial.
MED-02 is a complex supplement containing two probiotic strains, Limosilactobacillus fermentum MG4231 and MG4244, isolated from humans. The anti-obesity effects and safety profile of MED-02 were assessed in overweight and obese subjects. ...
MED-02 is a complex supplement containing two probiotic strains, Limosilactobacillus fermentum MG4231 and MG4244, isolated fro …
Lactobacillus fermentum (PCC) supplementation and gastrointestinal and respiratory-tract illness symptoms: a randomised control trial in athletes.
West NP, Pyne DB, Cripps AW, Hopkins WG, Eskesen DC, Jairath A, Christophersen CT, Conlon MA, Fricker PA. West NP, et al. Nutr J. 2011 Apr 11;10:30. doi: 10.1186/1475-2891-10-30. Nutr J. 2011. PMID: 21477383 Free PMC article. Clinical Trial.
METHODS: Competitive cyclists (64 males and 35 females; age 35 9 and 36 9 y, VO2max 56 6 and 52 6 ml.kg-1.min-1, mean SD) were randomised to either probiotic (minimum 1 109 Lactobacillus fermentum (PCC) per day) or placebo treatment for 11 weeks in a double-blind, randomis …
METHODS: Competitive cyclists (64 males and 35 females; age 35 9 and 36 9 y, VO2max 56 6 and 52 6 ml.kg-1.min-1, mean SD) were randomised to …
Effects of Lactobacillus fermentum CECT5716 Lc40 on infant growth and health: a randomised clinical trial in nursing women.
Pastor-Villaescusa B, Hurtado JA, Gil-Campos M, Uberos J, Maldonado-Lobón JA, Díaz-Ropero MP, Bañuelos O, Fonollá J, Olivares M; PROLAC Group. Pastor-Villaescusa B, et al. Benef Microbes. 2020 May 11;11(3):235-244. doi: 10.3920/BM2019.0180. Epub 2020 Mar 27. Benef Microbes. 2020. PMID: 32216468 Clinical Trial.
We studied the effect of Lactobacillus fermentum CECT5716 (Lc40) on growth and infection incidence of the infants, when the probiotic is administrated to the mothers. ...
We studied the effect of Lactobacillus fermentum CECT5716 (Lc40) on growth and infection incidence of the infants, when the probiotic …
Impact of supplementing Limosilactobacillus fermentum MN-LF23 on the eradication of Helicobacter pylori with 14-day standard quadruple therapy: a randomized, double-blind, placebo-controlled trial.
Zhao Y, Niu X, Zhang Y, Zhao L, Zhang L, He J, Zhang Q, Mao Y, Wang F, Zhao X, Wang R. Zhao Y, et al. Nutr J. 2025 Jul 7;24(1):106. doi: 10.1186/s12937-025-01124-6. Nutr J. 2025. PMID: 40624535 Free PMC article. Clinical Trial.
This study aims to elucidate the role of Limosilactobacillus fermentum MN-LF23 (MN-LF23) in Hp-infected populations. METHODS: A total of 94 adult patients with confirmed Hp infection were enrolled in this study and randomly allocated to the placebo or MN-LF23 group. …
This study aims to elucidate the role of Limosilactobacillus fermentum MN-LF23 (MN-LF23) in Hp-infected populations. METHODS: …
Can Lactobacillus fermentum LF10 and Lactobacillus acidophilus LA02 in a slow-release vaginal product be useful for prevention of recurrent vulvovaginal candidiasis?: A clinical study.
Murina F, Graziottin A, Vicariotto F, De Seta F. Murina F, et al. J Clin Gastroenterol. 2014 Nov-Dec;48 Suppl 1:S102-5. doi: 10.1097/MCG.0000000000000225. J Clin Gastroenterol. 2014. PMID: 25291115 Clinical Trial.
OBJECTIVE: To assess the effectiveness of the association of 2 specific strains, Lactobacillus fermentum LF10 (DSM 19187) and Lactobacillus acidophilus LA02 (DSM 21717), specifically formulated in slow-release effervescent tablets, in patients with recurrent vulvovaginal c …
OBJECTIVE: To assess the effectiveness of the association of 2 specific strains, Lactobacillus fermentum LF10 (DSM 19187) and Lactoba …
39 results